Dose reduction of bone morphogenetic protein-2 for bone regeneration using a delivery system based on lyophilization with trehalose.

about

Dose reduction of bone morphogenetic protein-2 for bone regeneration using a delivery system based on lyophilization with trehalose.

Item

http://www.wikidata.org/entity/Q49196453

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Dose reduction of bone morphog ...... lyophilization with trehalose.

@en

Dose reduction of bone morphog ...... lyophilization with trehalose.

@nl

type

Item

label

Dose reduction of bone morphog ...... lyophilization with trehalose.

@en

Dose reduction of bone morphog ...... lyophilization with trehalose.

@nl

prefLabel

Dose reduction of bone morphog ...... lyophilization with trehalose.

@en

Dose reduction of bone morphog ...... lyophilization with trehalose.

@nl

P1476

Dose reduction of bone morphog ...... lyophilization with trehalose.

@en

P2093

Jun Zhao

http://www.w3.org/2001/XMLSchema#string

Quan Yu

http://www.w3.org/2001/XMLSchema#string

Xiaochen Zhang

http://www.w3.org/2001/XMLSchema#string

Yan-An Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned

DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water.

Delivery of bone morphogenetic protein-2 and substance P using graphene oxide for bone regeneration

Lyophilization-induced reversible changes in the secondary structure of proteins.

Lyophilization and development of solid protein pharmaceuticals.

Factors affecting short-term and long-term stabilities of proteins.

Trehalose maintains bioactivity and promotes sustained release of BMP-2 from lyophilized CDHA scaffolds for enhanced osteogenesis in vitro and in vivo

Safety profile for the clinical use of bone morphogenetic proteins in the spine.

Use of bone morphogenetic proteins for musculoskeletal applications. An overview.

P304

403-414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJN.S150875

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29391797

http://www.w3.org/2001/XMLSchema#string

P921

alpha,alpha-trehalose

morphogenesis

P932

5769568

http://www.w3.org/2001/XMLSchema#string